Prescription Prior Authorization Guidelines: Understanding the Difference Between Medical Necessity, Coverage, and Precertification

Examine prescription prior authorization requirements, including PBM utilization management, diagnosis-specific criteria, step therapy protocols, quantity limits, and formulary exceptions….

Table of Contents

Prescription prior authorization is a utilization-management process used by health plans and pharmacy benefit managers to evaluate certain medications before coverage is granted under the patient’s prescription benefit. The process may require the prescriber to provide clinical information showing that the medication meets the plan’s coverage criteria. Our this guide provide you complete information about prescription prior authorization.

Critical Takeaways From This Guide

1. Why a Prescription Can Require Additional Approval

2. Start With the Patient’s Drug Benefit, Not the PA Form

3. Read the Pharmacy Rejection Before Choosing the Next Step

4. Review the Formulary Before Building the Clinical Case

5. Prior Authorization, Step Therapy, and Quantity Limits Solve Different Questions

6. Pharmacy Benefit or Medical Benefit?

7. A Strong PA Begins With the Coverage Criteria

8. Turn the Payer’s Questions Into a Clinical Narrative

9. Document Medication Trials With Enough Detail to Be Useful

10. Treatment Failure and Intolerance Are Not the Same

11. Diagnosis Coding Needs Clinical Support

12. Dose, Frequency, and Quantity Need Their Own Review

13. Quantity-Limit Requests Need a Focused Explanation

14. Step-Therapy Requests Need a Complete Treatment Sequence

15. Non-Formulary Requests Need More Than “Patient Prefers This Drug”

16. Specialty Medication PA Requires Broader Coordination

17. Injectable and Infused Medications Need Claim-Level Accuracy

18. Site of Care Can Become Part of Drug Authorization

19. Electronic Prior Authorization Is Changing Prescription Workflows

20. Real-Time Prescription Benefit Information Can Prevent Avoidable PA Work

21. The Regulatory Landscape Is Moving Toward Faster Drug PA

22. Medicaid Prescription PA Needs State-Level Verification

23. Medicare Part D Needs Its Own Authorization Logic

24. Commercial Plans Do Not Share One National PA Deadline

25. Submission Should Produce a Trackable Case

26. “Submitted” Is a Workflow Stage, Not an Outcome

27. Additional Information Requests Should Be Worked Immediately

28. Validate the Approval Before Closing the Case

29. Watch the Expiration Date From Day One

30. Renewal Requests Need Current Evidence

31. Why Prescription PA Requests Get Denied

32. Do Not Appeal Before Understanding the Denial

33. Construct Appeals Around the Adverse Decision

34. Urgent Requests Should Reflect Clinical Urgency

35. Create a Closed Loop With the Pharmacy

36. Keep the Patient Informed

37. Build a Prescription PA Tracking Dashboard

38. Prescription Authorization KPIs Worth Measuring

39. A Practical Prescription PA Sequence

40. Prescription Prior Authorization Pre-Submission Checklist

41. Frequently Asked Questions About Prescription Prior Authorization

42. Final Perspective

Why a Prescription Can Require Additional Approval

Health plans and PBMs use medication-management requirements for several reasons, and they may be designed to:

  • Confirm that a drug is being used for a covered indication
  • Determine whether medical-necessity criteria are met
  • Encourage use of preferred medications
  • Confirm previous treatment with alternatives
  • Manage medication safety
  • Control inappropriate utilization
  • Apply quantity or dosage limits
  • Direct specialty medications through specific channels
  • Manage high-cost therapies

You Must Start With the Patient’s Drug Benefit, Not the PA Form

The prescription benefit determines the authorization pathway, before starting a request you need to capture.

Verification ItemWhat to Confirm
PatientCorrect member
EligibilityCoverage active
Health planCurrent insurer
PBMPharmacy benefit administrator
Member IDCorrect identification
RxBINPharmacy routing information
RxPCNProcessor information
RxGroupBenefit group when applicable
MedicationExact drug
StrengthPrescribed strength
Dosage formTablet, capsule, solution, etc.
QuantityAmount prescribed
Days’ supplyIntended dispensing period
PharmacyCorrect/network pharmacy
BenefitPharmacy or medical

You Need to Read the Pharmacy Rejection Before Choosing the Next Step

The pharmacy claim can provide useful information about why the prescription did not process, and you do not reduce every rejection to, the insurance won’t cover it. Instead, determine whether the problem is involved in the process.

  • Prior authorization
  • Step therapy
  • Quantity limit
  • Non-formulary status
  • Refill timing
  • Pharmacy network
  • Eligibility
  • Days’ supply
  • Product selection
  • Specialty pharmacy
  • Benefit limitation
  • Another claim-processing edit

You Must review the Formulary Before Building the Clinical Case

A formulary is the plan’s covered-drug list, usually organized according to the plan’s benefit design. When checking a medication, look beyond whether its name appears, and need to review:

Drug → Formulation → Strength → Tier → PA → Step therapy → Quantity limit → Specialty requirements

A useful formulary verification record might contain the follow below information.

Drug DetailVerification
MedicationExact prescribed product
Generic/brandProduct requested
FormCorrect dosage form
StrengthCorrect strength
CoveredYes/No
TierApplicable tier
PARequired/not required
Step therapyRequirement present/absent
Quantity limitCurrent restriction
Preferred alternativeAvailable options
Specialty pharmacyRequirement if applicable

Prior Authorization, Step Therapy, and Quantity Limits Solve Different Questions

These terms are related but should not be used interchangeably.

Prior Authorization

The payer requires additional information before deciding whether the medication meets coverage requirements.

Step Therapy

The plan expects the patient to try one or more preferred therapies before covering another drug, unless an exception or other applicable criterion is satisfied.

Quantity Limit

The drug may be covered, but only up to a specified quantity during a particular period.

Formulary Exception

The prescribed medication may not be on the formulary, and the patient/prescriber seeks coverage based on the patient’s clinical circumstances where the applicable benefit permits an exception.

Tiering Exception

In certain benefit structures, the request concerns the cost-sharing tier rather than whether the drug is covered at all.

Pharmacy Benefit or Medical Benefit?

Before working on expensive injectable, infused, biologic, or specialty medications, determine which benefit is responsible. This can fundamentally change the authorization process.

Pharmacy Benefit

The drug may be dispensed through:

  • Retail pharmacy
  • Mail-order pharmacy
  • Specialty pharmacy

The request often uses pharmacy benefit information and medication-specific electronic PA workflows.

Medical Benefit

A drug administered by a healthcare professional may sometimes be billed through the medical benefit.

The request may instead involve:

  • HCPCS/J-code
  • Medical policy
  • Units
  • Infusion or administration setting
  • Rendering provider
  • Facility
  • Site of care

A Strong PA Begins With the Coverage Criteria

Authorization staff often work backward. They submit the medication and whatever notes are readily available, wait for a response, and then discover what documentation the payer wanted. A better process is:

Find criteria first → Review chart second → Identify evidence gaps → Ask clinician for missing information → Submit complete request

The criteria may ask for information involving:

  • Diagnosis
  • Disease severity
  • Previous medication trials
  • Treatment duration
  • Treatment response
  • Contraindications
  • Adverse reactions
  • Laboratory findings
  • Biomarkers
  • Comorbidities
  • Dose
  • Frequency
  • Age
  • Weight
  • Treatment setting

Diagnosis Coding Needs Clinical Support

Prescription authorization can involve both the written diagnosis and the supporting medical record. Before submitting, verify:

  • Diagnosis
  • ICD-10-CM code
  • Indication
  • Relevant clinical findings
  • Specialist involvement when relevant
  • Supporting laboratory or diagnostic evidence

Do not choose a diagnosis merely because it appears likely to satisfy the PA. The diagnosis submitted to the payer must accurately reflect the patient’s documented condition.

Step-Therapy Requests Need a Complete Treatment Sequence

When step therapy applies, map the patient’s previous treatment against the required sequence. A simple table can help:

Required TherapyPatient HistoryOutcome
Preferred Drug ATriedInadequate response
Preferred Drug BTriedIntolerable adverse effects
Preferred Drug CNot usedDocumented contraindication
Requested Drug DProposedClinical rationale documented

Specialty Medication PA Requires Broader Coordination

Specialty drugs can involve multiple administrative layers. The workflow may include:

Coverage verification

↓

Benefit determination

↓

PA

↓

Specialty pharmacy

↓

Network requirement

↓

Financial assistance/copay considerations where applicable

↓

Drug shipment

↓

Administration

↓

Renewal

Injectable and Infused Medications Need Claim-Level Accuracy

For drugs billed under a medical benefit, authorization staff should think ahead to the claim, you need to verify:

  • Drug
  • HCPCS/J-code
  • NDC when required
  • Diagnosis
  • Dose
  • HCPCS units
  • Frequency
  • Route
  • Rendering provider
  • Facility
  • Place of service
  • Administration date
  • Authorization period

Electronic Prior Authorization is Changing Prescription Workflows

Prescription PA is increasingly moving into electronic prescribing and EHR workflows. Electronic PA can allow information to move between the prescriber and payer without relying entirely on telephone and fax processes. Modern workflows can support:

PA initiation → Payer questions → Provider response → Clinical submission → Decision

Federal health IT standards are also moving further in this direction. For Medicare Part D, updated federal e-prescribing requirements are transitioning to NCPDP SCRIPT version 2023011, which supports prescription-related information including electronic prior authorization transactions. Beginning January 1, 2028, that version becomes the required Part D e-prescribing standard after the transition period.

Real-Time Prescription Benefit Information Can Prevent Avoidable PA Work

The future of prescription authorization is not only about submitting requests faster. It is also about identifying coverage restrictions earlier. Real-time prescription benefit technology can give prescribers information about medication coverage and alternatives during prescribing. That can help clinicians identify:

  • Patient-specific coverage
  • Potential alternatives
  • Benefit information
  • Cost considerations
  • Formulary issues

The Regulatory Landscape is Moving Toward Faster Drug PA

Prescription authorization policy continues to evolve. In April 2026, CMS proposed a major expansion of its electronic prior authorization framework specifically for drugs.

The proposal would extend electronic PA requirements to drugs under specified medical and pharmacy benefits for impacted federal-program payers. It also proposes decision standards of no later than 24 hours for urgent requests and 72 hours for standard requests for affected drug PA workflows. However, providers need to understand an important distinction:

These drug provisions are proposed as of October 2026. They should not be described as a universal current federal deadline applying to every commercial, Medicaid, Medicare, employer-sponsored, or PBM prescription authorization today. CMS states that the comment period for CMS-0062-P closed June 15, 2026.

Medicaid Prescription PA Needs State-Level Verification

Prescription coverage is available throughout state Medicaid programs, but Medicaid pharmacy policies remain highly state-specific. States may operate:

  • Preferred drug lists
  • Drug-specific PA
  • Clinical edits
  • Quantity limits
  • Step therapy
  • Supplemental rebate arrangements
  • Drug utilization review programs

Medicare Part D Needs Its Own Authorization Logic

Medicare Part D has a defined federal coverage-determination framework. Do not automatically apply commercial plan procedures or timelines to Part D. Part D can involve:

  • Prior authorization
  • Step therapy
  • Quantity limits
  • Formulary exceptions
  • Tiering exceptions
  • Standard coverage determinations
  • Expedited coverage determinations
  • Redeterminations and higher appeals

Commercial Plans Do Not Share One National PA Deadline

For commercial prescription coverage, timelines can depend on:

  • State law
  • Health plan
  • Employer plan
  • Fully insured versus self-funded coverage
  • Request type
  • Urgency
  • Drug
  • Benefit
  • Applicable federal requirements

Additional Information Requests Should Be Worked Immediately

If the payer asks for more information, identify exactly what is missing. Then assign the request to a named staff member. A good workflow is:

Payer request received → Missing element identified → Clinical owner assigned → Information collected → Submitted → Confirmation saved → Case status checked

Examples of requested information may include:

  • Chart notes
  • Lab results
  • Previous medication history
  • Diagnosis clarification
  • Dose
  • Treatment duration
  • Specialist notes
  • Contraindication
  • Treatment response

Watch the Expiration Date From Day One

Many prescription authorizations are temporary. Instead of discovering expiration during a refill, record:

Approval date

Effective date

Expiration date

Renewal lead time

For chronic therapy, consider beginning renewal preparation before expiration based on the payer’s rules and the patient’s next scheduled fill or administration. This gives the practice time to obtain updated records.

Renewal Requests Need Current Evidence

Do not assume the original clinical packet is sufficient forever. A renewal may need evidence showing:

  • Patient remains on treatment
  • Clinical response
  • Symptom improvement
  • Disease control
  • Current laboratory results
  • Continued diagnosis
  • Current dose
  • Treatment adherence
  • Absence of unacceptable toxicity
  • Continued medical necessity

Why Your Prescription PA Requests Get Denied

A denial can result from many different problems.

Missing Clinical Evidence

The submission does not contain enough information to evaluate the criteria.

Criteria Not Met

The records do not demonstrate the required clinical conditions.

Step Therapy Incomplete

Required alternatives have not been tried or adequately addressed.

Non-Formulary Drug

The request needs a different exception pathway.

Quantity Exceeded

The requested amount exceeds the plan’s standard limit.

Diagnosis Does Not Match Criteria

The submitted indication does not satisfy the applicable coverage rule.

Dose Is Unsupported

The regimen falls outside applicable parameters without sufficient justification.

Wrong Benefit

The request was routed through pharmacy coverage when the drug belongs under medical coverage, or vice versa.

Wrong PBM or Payer

Coverage changed or the benefit administrator was identified incorrectly.

Missing Prescriber Response

The PA was initiated but never completed.

Do Not Appeal Before Understanding the Denial

A denial does not automatically mean the payer made a mistake. Start with:

What did the payer decide?

Then:

Why?

Then:

What evidence would materially address that reason?

The next step might be:

  • Correcting missing information
  • Requesting reconsideration
  • Filing an appeal
  • Seeking an exception
  • Completing step therapy
  • Changing medication
  • Correcting the benefit pathway
  • Adjusting quantity
  • Providing additional clinical evidence

You Must Build a Prescription PA Tracking Dashboard

FieldWhat to Track
PatientCase owner
Member IDCoverage
Health planInsurer
PBMPharmacy administrator
Line of businessCommercial/Medicare/Medicaid/etc.
DrugRequested medication
StrengthPrescription detail
DoseTreatment regimen
QuantityRequested amount
Days’ supplyDispensing period
DiagnosisClinical indication
FormularyCovered/non-formulary
PARequirement
Step therapyRequirement
Quantity limitRestriction
Previous therapyClinical history
Request typePA/exception/etc.
Submission methodePA/portal/fax/etc.
SubmittedDate/time
ReferenceTracking number
PriorityStandard/urgent
DeadlineApplicable payer/program deadline
StatusCurrent stage
Additional infoOutstanding records
DecisionOutcome
Effective dateApproval start
ExpirationRenewal date
AppealCurrent status
Pharmacy notifiedCommunication
Patient notifiedCommunication
Claim processedFinal closure

A Practical Prescription PA Sequence

A mature process can follow this order:

1. Receive prescription or pharmacy rejection

2. Verify active insurance

3. Identify the pharmacy benefit/PBM

4. Confirm pharmacy versus medical benefit

5. Review formulary

6. Identify the exact restriction

7. Locate current clinical criteria

8. Review the patient’s chart against those criteria

9. Obtain missing clinical information

10. Document previous therapy accurately

11. Validate dose and quantity

12. Select the correct PA/exception pathway

13. Submit through the accepted channel

14. Save confirmation and reference number

15. Record the applicable deadline

16. Monitor the request

17. Respond to additional-information requests

18. Validate the determination

19. Notify pharmacy and patient

20. Confirm successful dispensing

21. Record authorization expiration

22. Prepare renewal before coverage lapses

Prescription Prior Authorization Pre-Submission Checklist

Before clicking submit, confirm:

  • Patient coverage is active
  • Correct payer is identified
  • Correct PBM is identified
  • Correct member information is entered
  • Pharmacy versus medical benefit is verified
  • Exact drug is selected
  • Correct formulation is selected
  • Correct strength is entered
  • Dose is accurate
  • Frequency is accurate
  • Quantity is correct
  • Days’ supply is correct
  • Diagnosis is documented
  • ICD-10-CM is accurate
  • Formulary status has been reviewed
  • PA requirement has been confirmed
  • Step therapy has been reviewed
  • Quantity limits have been checked
  • Preferred alternatives have been reviewed
  • Current clinical criteria have been checked
  • Previous therapy is documented
  • Treatment response is documented
  • Adverse effects are documented
  • Contraindications are documented
  • Relevant laboratory results are included
  • Specialist records are included when needed
  • Correct request type is selected
  • Appropriate urgency is selected
  • Required attachments are included
  • Prescriber attestation/signature requirements are complete
  • Submission method is correct
  • Follow-up responsibility is assigned

Frequently Asked Questions About Prescription Prior Authorization

What is prescription prior authorization?

Prescription prior authorization is a coverage process in which a health plan or pharmacy benefit administrator requires additional information before approving coverage for certain medications.

Why would insurance require PA for a medication?

A plan may use PA to evaluate diagnosis, medical necessity, treatment history, safety, formulary alternatives, dose, quantity or other coverage criteria.

Is prior authorization the same as step therapy?

No, PA requires coverage review, while step therapy generally requires use of specified preferred treatment before another medication is covered unless applicable exception criteria are satisfied.

Is a quantity limit the same as a PA?

Not necessarily. A drug may be covered but limited to a specified amount. A separate quantity-limit exception or authorization process may be available depending on the benefit.

Can a covered formulary drug still require authorization?

Yes, formulary inclusion does not necessarily eliminate PA, step therapy, quantity limits or other utilization-management requirements.

What information is commonly needed for a medication PA?

Common information includes diagnosis, medication, dose, quantity, treatment history, previous drug response, adverse effects, contraindications, laboratory results and other drug-specific clinical evidence.

Who submits prescription prior authorization?

The prescribing provider or authorized clinical staff commonly supplies the clinical information, although workflows can involve pharmacies, electronic prescribing systems, PBMs and health plans.

Can PA be completed electronically?

Yes, electronic prior authorization is increasingly integrated with electronic prescribing and EHR technology. Federal standards are also expanding electronic PA capabilities.

How long does prescription prior authorization take?

There is no single universal timeframe for every prescription PA. The applicable deadline depends on factors such as payer, benefit, program, state law, request type and urgency.

Is there a universal 72-hour prescription PA rule?

No, certain programs have specific deadlines, and CMS proposed broader 72-hour standard/24-hour urgent drug PA standards in 2026 for specified impacted payers, but that proposal should not be presented as a universal rule currently governing every prescription plan.

Can the patient get medication while PA is pending?

That depends on the drug, benefit and circumstances. Certain programs may provide transition or emergency-supply protections. Providers and pharmacies should check the patient’s specific plan requirements.

What happens if step therapy has already been completed?

Document the medication, dose, duration and clinical outcome clearly and submit the evidence required by the plan.

Related Prior Authorization Guides

Need Expert Help With Prescription Prior Authorization Guidelines: Understanding the Difference Between Medical Necessity, Coverage, and Precertification?

Let our certified billing specialists handle coding, claims and denials so you can focus on patient care. Talk to our team today.